Bristol Myers Squibb (BMY) Goodwill (2009 - 2026)
Bristol Myers Squibb's (BMY) quarterly Goodwill came in at $21.7 billion in Q2 2026, little changed year-over-year from $21.8 billion in Q2 2025, and little changed quarter-over-quarter from $21.7 billion in Q1 2026.
Analysis
Bristol Myers Squibb (BMY) Goodwill (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (BMY) has reported Goodwill for 18 consecutive years, with $21.7 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Goodwill changed 0.17% year-over-year to $21.7 billion in Q2 2026; TTM through Jun 2026 was $21.7 billion, a 0.17% change from a year earlier, with the FY2025 full-year figure at $21.8 billion, changed 0.16% from the prior year.
- Goodwill was $21.7 billion for Q2 2026 at Bristol Myers Squibb, roughly flat from $21.7 billion in the prior quarter.
- Over five years, Goodwill peaked at $21.8 billion in Q2 2025 and troughed at $20.4 billion in Q2 2022.
- A 5-year average of $21.4 billion and a median of $21.7 billion in 2024 frame the typical range for Goodwill.
- Across the five-year window, Goodwill slipped 0.4% in 2022 and grew 3.51% in 2023, its largest moves.
- Over 5 years, Goodwill stood at $21.1 billion in 2022, then grew by 0.09% to $21.2 billion in 2023, then climbed by 2.6% to $21.7 billion in 2024, then advanced by 0.16% to $21.8 billion in 2025, then declined by 0.06% to $21.7 billion in 2026.
- The last three Goodwill figures came in at $21.7 billion (Q2 2026), $21.7 billion (Q1 2026), and $21.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.74 Bn |
| Mar 31, 2026 | 21.74 Bn |
| Dec 31, 2025 | 21.75 Bn |
| Sep 30, 2025 | 21.75 Bn |
| Jun 30, 2025 | 21.78 Bn |
| Mar 31, 2025 | 21.74 Bn |
| Dec 31, 2024 | 21.72 Bn |
| Sep 30, 2024 | 21.75 Bn |
| Jun 30, 2024 | 21.73 Bn |
| Mar 31, 2024 | 21.74 Bn |
| Dec 31, 2023 | 21.17 Bn |
| Sep 30, 2023 | 21.15 Bn |
| Jun 30, 2023 | 21.16 Bn |
| Mar 31, 2023 | 21.16 Bn |
| Dec 31, 2022 | 21.15 Bn |
| Sep 30, 2022 | 21.11 Bn |
| Jun 30, 2022 | 20.45 Bn |
| Mar 31, 2022 | 20.50 Bn |
| Dec 31, 2021 | 20.50 Bn |
| Sep 30, 2021 | 20.52 Bn |